Global Cancer Immunotherapy Market Research Report Forecast 2017-2021

September 2017 | 103 pages | ID: GF7576A771DEN
S&P Consulting

Abstracts

The Global Cancer Immunotherapy Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Cancer Immunotherapy industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Cancer Immunotherapy market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

Global Cancer Immunotherapy Market: Regional Segment Analysis
North America
Europe
China
Japan
Southeast Asia
India

The Major players reported in the market include:
Amgen
AstraZeneca
F. Hoffman La-Roche
Bayer AG
Bristol-Myers Squibb
Eli Lilly and Company
Janssen Global Services
Merck
Novartis

Global Cancer Immunotherapy Market: Product Segment Analysis
Type 1
Type 2
Type 3


Global Cancer Immunotherapy Market: Application Segment Analysis
Application 1
Application 2
Application 3

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Contents

CHAPTER 1 CANCER IMMUNOTHERAPY MARKET OVERVIEW

1.1 Product Overview and Scope of Cancer Immunotherapy
1.2 Cancer Immunotherapy Market Segmentation by Type
  1.2.1 Global Production Market Share of Cancer Immunotherapy by Type in 2015
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Cancer Immunotherapy Market Segmentation by Application
  1.3.1 Cancer Immunotherapy Consumption Market Share by Application in 2015
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Cancer Immunotherapy Market Segmentation by Regions
  1.4.1 North America
  1.4.2 China
  1.4.3 Europe
  1.4.4 Southeast Asia
  1.4.5 Japan
  1.4.6 India
1.5 Global Market Size (Value) of Cancer Immunotherapy (2012-2021)

CHAPTER 2 GLOBAL ECONOMIC IMPACT ON CANCER IMMUNOTHERAPY INDUSTRY

2.1 Global Macroeconomic Environment Analysis
  2.1.1 Global Macroeconomic Analysis
  2.1.2 Global Macroeconomic Environment Development Trend
2.2 Global Macroeconomic Environment Analysis by Regions

CHAPTER 3 GLOBAL CANCER IMMUNOTHERAPY MARKET COMPETITION BY MANUFACTURERS

3.1 Global Cancer Immunotherapy Production and Share by Manufacturers (2015 and 2016)
3.2 Global Cancer Immunotherapy Revenue and Share by Manufacturers (2015 and 2016)
3.3 Global Cancer Immunotherapy Average Price by Manufacturers (2015 and 2016)
3.4 Manufacturers Cancer Immunotherapy Manufacturing Base Distribution, Production Area and Product Type
3.5 Cancer Immunotherapy Market Competitive Situation and Trends
  3.5.1 Cancer Immunotherapy Market Concentration Rate
  3.5.2 Cancer Immunotherapy Market Share of Top 3 and Top 5 Manufacturers
  3.5.3 Mergers & Acquisitions, Expansion

CHAPTER 4 GLOBAL CANCER IMMUNOTHERAPY PRODUCTION, REVENUE (VALUE) BY REGION (2012-2017)

4.1 Global Cancer Immunotherapy Production by Region (2012-2017)
4.2 Global Cancer Immunotherapy Production Market Share by Region (2012-2017)
4.3 Global Cancer Immunotherapy Revenue (Value) and Market Share by Region (2012-2017)
4.4 Global Cancer Immunotherapy Production, Revenue, Price and Gross Margin (2012-2017)
4.5 North America Cancer Immunotherapy Production, Revenue, Price and Gross Margin (2012-2017)
4.6 Europe Cancer Immunotherapy Production, Revenue, Price and Gross Margin (2012-2017)
4.7 China Cancer Immunotherapy Production, Revenue, Price and Gross Margin (2012-2017)
4.8 Japan Cancer Immunotherapy Production, Revenue, Price and Gross Margin (2012-2017)
4.9 Southeast Asia Cancer Immunotherapy Production, Revenue, Price and Gross Margin (2012-2017)
4.10 India Cancer Immunotherapy Production, Revenue, Price and Gross Margin (2012-2017)

CHAPTER 5 GLOBAL CANCER IMMUNOTHERAPY SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGIONS (2012-2017)

5.1 Global Cancer Immunotherapy Consumption by Regions (2012-2017)
5.2 North America Cancer Immunotherapy Production, Consumption, Export, Import by Regions (2012-2017)
5.3 Europe Cancer Immunotherapy Production, Consumption, Export, Import by Regions (2012-2017)
5.4 China Cancer Immunotherapy Production, Consumption, Export, Import by Regions (2012-2017)
5.5 Japan Cancer Immunotherapy Production, Consumption, Export, Import by Regions (2012-2017)
5.6 Southeast Asia Cancer Immunotherapy Production, Consumption, Export, Import by Regions (2012-2017)
5.7 India Cancer Immunotherapy Production, Consumption, Export, Import by Regions (2012-2017)

CHAPTER 6 GLOBAL CANCER IMMUNOTHERAPY PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

6.1 Global Cancer Immunotherapy Production and Market Share by Type (2012-2017)
6.2 Global Cancer Immunotherapy Revenue and Market Share by Type (2012-2017)
6.3 Global Cancer Immunotherapy Price by Type (2012-2017)
6.4 Global Cancer Immunotherapy Production Growth by Type (2012-2017)

CHAPTER 7 GLOBAL CANCER IMMUNOTHERAPY MARKET ANALYSIS BY APPLICATION

7.1 Global Cancer Immunotherapy Consumption and Market Share by Application (2012-2017)
7.2 Global Cancer Immunotherapy Consumption Growth Rate by Application (2012-2017)
7.3 Market Drivers and Opportunities
  7.3.1 Potential Applications
  7.3.2 Emerging Markets/Countries

CHAPTER 8 GLOBAL CANCER IMMUNOTHERAPY MANUFACTURERS ANALYSIS

8.1 Amgen
  8.1.1 Company Basic Information, Manufacturing Base and Competitors
  8.1.2 Product Type, Application and Specification
  8.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.1.4 Business Overview
8.2 AstraZeneca
  8.2.1 Company Basic Information, Manufacturing Base and Competitors
  8.2.2 Product Type, Application and Specification
  8.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.2.4 Business Overview
8.3 F. Hoffman La-Roche
  8.3.1 Company Basic Information, Manufacturing Base and Competitors
  8.3.2 Product Type, Application and Specification
  8.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.3.4 Business Overview
8.4 Bayer AG
  8.4.1 Company Basic Information, Manufacturing Base and Competitors
  8.4.2 Product Type, Application and Specification
  8.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.4.4 Business Overview
8.5 Bristol-Myers Squibb
  8.5.1 Company Basic Information, Manufacturing Base and Competitors
  8.5.2 Product Type, Application and Specification
  8.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.5.4 Business Overview
8.6 Eli Lilly and Company
  8.6.1 Company Basic Information, Manufacturing Base and Competitors
  8.6.2 Product Type, Application and Specification
  8.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.6.4 Business Overview
8.7 Janssen Global Services
  8.7.1 Company Basic Information, Manufacturing Base and Competitors
  8.7.2 Product Type, Application and Specification
  8.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.7.4 Business Overview
8.8 Merck
  8.8.1 Company Basic Information, Manufacturing Base and Competitors
  8.8.2 Product Type, Application and Specification
  8.8.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.8.4 Business Overview
8.9 Novartis
  8.9.1 Company Basic Information, Manufacturing Base and Competitors
  8.9.2 Product Type, Application and Specification
  8.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.9.4 Business Overview

CHAPTER 9 CANCER IMMUNOTHERAPY MANUFACTURING COST ANALYSIS

9.1 Cancer Immunotherapy Key Raw Materials Analysis
  9.1.1 Key Raw Materials
  9.1.2 Price Trend of Key Raw Materials
  9.1.3 Key Suppliers of Raw Materials
  9.1.4 Market Concentration Rate of Raw Materials
9.2 Proportion of Manufacturing Cost Structure
  9.2.1 Raw Materials
  9.2.2 Labor Cost
  9.2.3 Manufacturing Expenses
9.3 Manufacturing Process Analysis of Cancer Immunotherapy

CHAPTER 10 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

10.1 Cancer Immunotherapy Industrial Chain Analysis
10.2 Upstream Raw Materials Sourcing
10.3 Raw Materials Sources of Cancer Immunotherapy Major Manufacturers in 2015
10.4 Downstream Buyers

CHAPTER 11 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

11.1 Marketing Channel
  11.1.1 Direct Marketing
  11.1.2 Indirect Marketing
  11.1.3 Marketing Channel Development Trend
11.2 Market Positioning
  11.2.1 Pricing Strategy
  11.2.2 Brand Strategy
  11.2.3 Target Client
11.3 Distributors/Traders List

CHAPTER 12 MARKET EFFECT FACTORS ANALYSIS

12.1 Technology Progress/Risk
  12.1.1 Substitutes Threat
  12.1.2 Technology Progress in Related Industry
12.2 Consumer Needs/Customer Preference Change
12.3 Economic/Political Environmental Change

CHAPTER 13 GLOBAL CANCER IMMUNOTHERAPY MARKET FORECAST (2017-2021)

13.1 Global Cancer Immunotherapy Production, Revenue Forecast (2017-2021)
13.2 Global Cancer Immunotherapy Production, Consumption Forecast by Regions (2017-2021)
13.3 Global Cancer Immunotherapy Production Forecast by Type (2017-2021)
13.4 Global Cancer Immunotherapy Consumption Forecast by Application (2017-2021)
13.5 Cancer Immunotherapy Price Forecast (2017-2021)

CHAPTER 14 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Cancer Immunotherapy
Figure Global Production Market Share of Cancer Immunotherapy by Type in 2015
Figure Product Picture of Type I
Table Major Manufacturers of Type I
Figure Product Picture of Type II
Table Major Manufacturers of Type II
Figure Product Picture of Type III
Table Major Manufacturers of Type III
Table Cancer Immunotherapy Consumption Market Share by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Application 3 Examples
Figure North America Cancer Immunotherapy Revenue (Million USD) and Growth Rate (2012-2021)
Figure Europe Cancer Immunotherapy Revenue (Million USD) and Growth Rate (2012-2021)
Figure China Cancer Immunotherapy Revenue (Million USD) and Growth Rate (2012-2021)
Figure Japan Cancer Immunotherapy Revenue (Million USD) and Growth Rate (2012-2021)
Figure Southeast Asia Cancer Immunotherapy Revenue (Million USD) and Growth Rate (2012-2021)
Figure India Cancer Immunotherapy Revenue (Million USD) and Growth Rate (2012-2021)
Figure Global Cancer Immunotherapy Revenue (Million UDS) and Growth Rate (2012-2021)
Table Global Cancer Immunotherapy Capacity of Key Manufacturers (2015 and 2016)
Table Global Cancer Immunotherapy Capacity Market Share by Manufacturers (2015 and 2016)
Figure Global Cancer Immunotherapy Capacity of Key Manufacturers in 2015
Figure Global Cancer Immunotherapy Capacity of Key Manufacturers in 2016
Table Global Cancer Immunotherapy Production of Key Manufacturers (2015 and 2016)
Table Global Cancer Immunotherapy Production Share by Manufacturers (2015 and 2016)
Figure 2015 Cancer Immunotherapy Production Share by Manufacturers
Figure 2016 Cancer Immunotherapy Production Share by Manufacturers
Table Global Cancer Immunotherapy Revenue (Million USD) by Manufacturers (2015 and 2016)
Table Global Cancer Immunotherapy Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Cancer Immunotherapy Revenue Share by Manufacturers
Table 2016 Global Cancer Immunotherapy Revenue Share by Manufacturers
Table Global Market Cancer Immunotherapy Average Price of Key Manufacturers (2015 and 2016)
Figure Global Market Cancer Immunotherapy Average Price of Key Manufacturers in 2015
Table Manufacturers Cancer Immunotherapy Manufacturing Base Distribution and Sales Area
Table Manufacturers Cancer Immunotherapy Product Type
Figure Cancer Immunotherapy Market Share of Top 3 Manufacturers
Figure Cancer Immunotherapy Market Share of Top 5 Manufacturers
Table Global Cancer Immunotherapy Capacity by Regions (2012-2017)
Figure Global Cancer Immunotherapy Capacity Market Share by Regions (2012-2017)
Figure Global Cancer Immunotherapy Capacity Market Share by Regions (2012-2017)
Figure 2015 Global Cancer Immunotherapy Capacity Market Share by Regions
Table Global Cancer Immunotherapy Production by Regions (2012-2017)
Figure Global Cancer Immunotherapy Production and Market Share by Regions (2012-2017)
Figure Global Cancer Immunotherapy Production Market Share by Regions (2012-2017)
Figure 2015 Global Cancer Immunotherapy Production Market Share by Regions
Table Global Cancer Immunotherapy Revenue by Regions (2012-2017)
Table Global Cancer Immunotherapy Revenue Market Share by Regions (2012-2017)
Table 2015 Global Cancer Immunotherapy Revenue Market Share by Regions
Table Global Cancer Immunotherapy Production, Revenue, Price and Gross Margin (2012-2017)
Table North America Cancer Immunotherapy Production, Revenue, Price and Gross Margin (2012-2017)
Table Europe Cancer Immunotherapy Production, Revenue, Price and Gross Margin (2012-2017)
Table China Cancer Immunotherapy Production, Revenue, Price and Gross Margin (2012-2017)
Table Japan Cancer Immunotherapy Production, Revenue, Price and Gross Margin (2012-2017)
Table Southeast Asia Cancer Immunotherapy Production, Revenue, Price and Gross Margin (2012-2017)
Table India Cancer Immunotherapy Production, Revenue, Price and Gross Margin (2012-2017)
Table Global Cancer Immunotherapy Consumption Market by Regions (2012-2017)
Table Global Cancer Immunotherapy Consumption Market Share by Regions (2012-2017)
Figure Global Cancer Immunotherapy Consumption Market Share by Regions (2012-2017)
Figure 2015 Global Cancer Immunotherapy Consumption Market Share by Regions
Table North America Cancer Immunotherapy Production, Consumption, Import & Export (2012-2017)
Table Europe Cancer Immunotherapy Production, Consumption, Import & Export (2012-2017)
Table China Cancer Immunotherapy Production, Consumption, Import & Export (2012-2017)
Table Japan Cancer Immunotherapy Production, Consumption, Import & Export (2012-2017)
Table Southeast Asia Cancer Immunotherapy Production, Consumption, Import & Export (2012-2017)
Table India Cancer Immunotherapy Production, Consumption, Import & Export (2012-2017)
Table Global Cancer Immunotherapy Production by Type (2012-2017)
Table Global Cancer Immunotherapy Production Share by Type (2012-2017)
Figure Production Market Share of Cancer Immunotherapy by Type (2012-2017)
Figure 2015 Production Market Share of Cancer Immunotherapy by Type
Table Global Cancer Immunotherapy Revenue by Type (2012-2017)
Table Global Cancer Immunotherapy Revenue Share by Type (2012-2017)
Figure Production Revenue Share of Cancer Immunotherapy by Type (2012-2017)
Figure 2015 Revenue Market Share of Cancer Immunotherapy by Type
Table Global Cancer Immunotherapy Price by Type (2012-2017)
Figure Global Cancer Immunotherapy Production Growth by Type (2012-2017)
Table Global Cancer Immunotherapy Consumption by Application (2012-2017)
Table Global Cancer Immunotherapy Consumption Market Share by Application (2012-2017)
Figure Global Cancer Immunotherapy Consumption Market Share by Application in 2015
Table Global Cancer Immunotherapy Consumption Growth Rate by Application (2012-2017)
Figure Global Cancer Immunotherapy Consumption Growth Rate by Application (2012-2017)
Table Amgen Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Amgen Cancer Immunotherapy Production, Revenue, Price and Gross Margin (2012-2017)
Table Amgen Cancer Immunotherapy Market Share (2012-2017)
Table AstraZeneca Basic Information, Manufacturing Base, Production Area and Its Competitors
Table AstraZeneca Cancer Immunotherapy Production, Revenue, Price and Gross Margin (2012-2017)
Table AstraZeneca Cancer Immunotherapy Market Share (2012-2017)
Table F. Hoffman La-Roche Basic Information, Manufacturing Base, Production Area and Its Competitors
Table F. Hoffman La-Roche Cancer Immunotherapy Production, Revenue, Price and Gross Margin (2012-2017)
Table F. Hoffman La-Roche Cancer Immunotherapy Market Share (2012-2017)
Table Bayer AG Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Bayer AG Cancer Immunotherapy Production, Revenue, Price and Gross Margin (2012-2017)
Table Bayer AG Cancer Immunotherapy Market Share (2012-2017)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Bristol-Myers Squibb Cancer Immunotherapy Production, Revenue, Price and Gross Margin (2012-2017)
Table Bristol-Myers Squibb Cancer Immunotherapy Market Share (2012-2017)
Table Eli Lilly and Company Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Eli Lilly and Company Cancer Immunotherapy Production, Revenue, Price and Gross Margin (2012-2017)
Table Eli Lilly and Company Cancer Immunotherapy Market Share (2012-2017)
Table Janssen Global Services Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Janssen Global Services Cancer Immunotherapy Production, Revenue, Price and Gross Margin (2012-2017)
Table Janssen Global Services Cancer Immunotherapy Market Share (2012-2017)
Table Merck Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Merck Cancer Immunotherapy Production, Revenue, Price and Gross Margin (2012-2017)
Table Merck Cancer Immunotherapy Market Share (2012-2017)
Table Novartis Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Novartis Cancer Immunotherapy Production, Revenue, Price and Gross Margin (2012-2017)
Table Novartis Cancer Immunotherapy Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Cancer Immunotherapy
Figure Manufacturing Process Analysis of Cancer Immunotherapy
Figure Cancer Immunotherapy Industrial Chain Analysis
Table Raw Materials Sources of Cancer Immunotherapy Major Manufacturers in 2015
Table Major Buyers of Cancer Immunotherapy
Table Distributors/Traders List
Figure Global Cancer Immunotherapy Production and Growth Rate Forecast (2017-2021)
Figure Global Cancer Immunotherapy Revenue and Growth Rate Forecast (2017-2021)
Table Global Cancer Immunotherapy Production Forecast by Regions (2017-2021)
Table Global Cancer Immunotherapy Consumption Forecast by Regions (2017-2021)
Table Global Cancer Immunotherapy Production Forecast by Type (2017-2021)
Table Global Cancer Immunotherapy Consumption Forecast by Application (2017-2021)

COMPANIES MENTIONED

Amgen
AstraZeneca
F. Hoffman La-Roche
Bayer AG
Bristol-Myers Squibb
Eli Lilly and Company
Janssen Global Services
Merck
Novartis
Pfizer
Seattle Genetics
Peregrine Pharmaceuticals
Viralytics Ltd
Immunomedics